Randomised Double Blind Placebo Controlled Cross Over Design of the Efficacy of Topical Morphine for Inflammatory Pain in Children With Epidermolysis Bullosa

This study has been completed.
Information provided by:
Institute of Child Health
ClinicalTrials.gov Identifier:
First received: October 3, 2005
Last updated: October 11, 2006
Last verified: October 2005
Randomised Double blind placebo controlled cross over design study of the efficacy of morphine for inflammatory pain in children with Epidermolysis Bullosa

Condition Intervention Phase
Epidermylosis Bullosa
Drug: topical opiod
Drug: morphine sulphate in intrasite gel
Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Crossover Assignment
Masking: Double-Blind
Primary Purpose: Treatment

Resource links provided by NLM:

Further study details as provided by Institute of Child Health:


Ages Eligible for Study:   4 Years to 18 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • children under 18 years epidermolysis wounds requiring dressing changes
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00231517

United Kingdom
Great Ormond Street Hospital and the Institute of Child health
London, United Kingdom, WC1N 1EH
Sponsors and Collaborators
Institute of Child Health
Principal Investigator: Richard Howard, Prof Institute of Child Health
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00231517     History of Changes
Other Study ID Numbers: 01MH17 
Study First Received: October 3, 2005
Last Updated: October 11, 2006
Health Authority: United Kingdom: Research Ethics Committee

Additional relevant MeSH terms:
Analgesics, Opioid
Central Nervous System Agents
Central Nervous System Depressants
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses

ClinicalTrials.gov processed this record on February 07, 2016